Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

JDE De Rooij, R Masetti… - Blood, The Journal …, 2016 - ashpublications.org
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

[HTML][HTML] Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

JDE de Rooij, R Masetti, MM van den Heuvel-Eibrink… - Blood, 2016 - Elsevier
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

Recurrent abnormalities can be used for risk group stratification in pediatric amkl. a retrospective intergroup study

JDE De Rooij, R Masetti, V Den Heuvel-Eibrink… - BLOOD, 2016 - iris.uniroma1.it
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

[HTML][HTML] Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

JDE de Rooij, R Masetti, MM van den Heuvel-Eibrink… - Blood, 2016 - ncbi.nlm.nih.gov
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

[引用][C] Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study

JDE De Rooij, R Masetti, MM Van Den Heuvel Eibrink… - BLOOD, 2016 - iris.unipv.it
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective
intergroup study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study

JDE De Rooij, R Masetti, V Den Heuvel-Eibrink… - BLOOD, 2016 - publicatt.unicatt.it
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

Recurrent genetic abnormalities can be used for risk-group stratification in pediatric AMKL: results of a retrospective intergroup study

JDE de Rooij, R Masetti, MM van den Heuvel Eibrink… - BLOOD, 2016 - research.unipd.it
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

[PDF][PDF] Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

K GLIS - 2016 - academia.edu
Pediatric acute myeloid leukemia (AML) is a heterogeneous disease characterized by
recurrent genetic aberrations. The most important factors predicting clinical outcome are …

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study

J de Rooij, R Masetti, M van den Heuvel-Eibrink… - Blood, 2016 - repub.eur.nl
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study

JDE De Rooij, R Masetti, V Den Heuvel-Eibrink… - BLOOD, 2016 - cris.unibo.it
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …